Evaluation of Dendritic Cell Products Generated for Human Therapy and Post-Treatment Immune Monitoring.
| Publicado en: | BioPharm International Vol. 21; no. 3; pp. 42 - 68 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Mar2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108042100&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108042100 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Mar2008 vid: 21 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108042100 2011968488 108042100 ppf: 42 ppct: 26 formats: fmt: @attributes: type: P tig: atl: Evaluation of Dendritic Cell Products Generated for Human Therapy and Post-Treatment Immune Monitoring. aug: au: Whiteside, Theresa L. affil: Professor, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Director of the Immunologic Monitoring and Cellular Products Laboratory (IMCPL), Pittsburgh, PA sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|